2014
DOI: 10.1016/j.jhep.2013.11.023
|View full text |Cite
|
Sign up to set email alerts
|

HOPE for human liver grafts obtained from donors after cardiac death

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
295
0
3

Year Published

2015
2015
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 290 publications
(310 citation statements)
references
References 40 publications
8
295
0
3
Order By: Relevance
“…In parallel, the Zurich group introduced into clinical practice hypothermic oxygenated machine perfusion. 5 The advantage of cold perfusion is its simplicity and resultant low risk of device failure-related graft loss. NMLP is technically more challenging, and therefore, carries a small risk of graft loss related to the device malfunction.…”
Section: Discussionmentioning
confidence: 99%
“…In parallel, the Zurich group introduced into clinical practice hypothermic oxygenated machine perfusion. 5 The advantage of cold perfusion is its simplicity and resultant low risk of device failure-related graft loss. NMLP is technically more challenging, and therefore, carries a small risk of graft loss related to the device malfunction.…”
Section: Discussionmentioning
confidence: 99%
“…During end-ischemic MP and ex situ reperfusion, the perfusion fluid was oxygenated with 100% O 2 , and the PO 2 was 60 to 80 kPa (450-600 mm Hg), as described previously. 8,11,15,19 …”
Section: Scs End-ischemic Mp and Ex Situ Reperfusionmentioning
confidence: 99%
“…5,6 Although recent data from animal models and (discarded) human donor livers have provided promising results suggesting that endischemic MP has relevant protective effects on the bile ducts of donation after cardiac death (DCD) liver grafts, the most optimal perfusion temperature during end-ischemic MP has not been investigated. [7][8][9][10][11][12][13][14][15][16][17] The aim of this study was, therefore, to assess the optimal perfusion temperature during end-ischemic oxygenated MP for protection of the large bile ducts against I/R injury in a DCD rat liver model.…”
mentioning
confidence: 99%
“…After death declaration, a rapid laparotomy followed by aortic cannulation is performed, with perfusion of cold organ-preservation solution and decompression of the venous system. At other centers, instead of aortic cannulation, femoral vessels are cannulated either premortem (14,15) or postmortem (7), with a double-balloon triple-lumen (DBTL) catheter (7,15). Once death is declared, a cold preservation solution is perfused (in situ cold perfusion [ISP]), and blood is discharged through the femoral vein cannula.…”
Section: Consentmentioning
confidence: 99%
“…Several countries have reported cDCDD outcomes: the Netherlands (3), the United Kingdom (4), Canada (5), the United States (6), Switzerland (7), and Australia (8). Only a few cDCDD centers, however, have reported the use of extracorporeal membrane oxygenation (ECMO) to improve future graft outcome, including National Taiwan University Hospital, Taiwan (9); the University of Michigan, Ann Arbor, Michigan (10); the Henry Ford Health System, Detroit, Michigan (11); Wake Forest University, WinstonSalem, North Carolina (2); and three centers (Cambridge, Birmingham, and Edinburgh) in the United Kingdom (12).…”
Section: Introductionmentioning
confidence: 99%